Stonebridge Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$255K	Hold	485	–	–	0.1%	79
2025 Q1	$308K	Sell	485 -250	-34%	-$159K	0.13%	69
2024 Q4	$524K	Hold	735	–	–	0.21%	60
2024 Q3	$773K	Hold	735	–	–	0.31%	48
2024 Q2	$773K	Hold	735	–	–	0.33%	48
2024 Q1	$707K	Hold	735	–	–	0.32%	49
2023 Q4	$646K	Hold	735	–	–	0.32%	49
2023 Q3	$605K	Sell	735 -10	-1%	-$8.23K	0.33%	48
2023 Q2	$535K	Hold	745	–	–	0.25%	58
2023 Q1	$612K	Hold	745	–	–	0.29%	55
2022 Q4	$538K	Sell	745 -175	-19%	-$126K	0.26%	57
2022 Q3	$634K	Hold	920	–	–	0.33%	49
2022 Q2	$544K	Hold	920	–	–	0.25%	60
2022 Q1	$643K	Hold	920	–	–	0.23%	60
2021 Q4	$581K	Hold	920	–	–	0.2%	63
2021 Q3	$556K	Hold	920	–	–	0.2%	63
2021 Q2	$514K	Hold	920	–	–	0.19%	67
2021 Q1	$435K	Hold	920	–	–	0.17%	69
2020 Q4	$445K	Hold	920	–	–	0.18%	67
2020 Q3	$515K	Hold	920	–	–	0.24%	59
2020 Q2	$560K	Sell	920 -50	-5%	-$30.4K	0.29%	52
2020 Q1	$474K	Sell	970 -50	-5%	-$24.4K	0.27%	60
2019 Q4	$383K	Sell	1,020 -75	-7%	-$28.2K	0.17%	79
2019 Q3	$304K	Sell	1,095 -324	-23%	-$90K	0.14%	85
2019 Q2	$445K	Sell	1,419 -740	-34%	-$232K	0.18%	80
2019 Q1	$887K	Sell	2,159 -60	-3%	-$24.7K	0.32%	60
2018 Q4	$829K	Sell	2,219 -25	-1%	-$9.34K	0.33%	63
2018 Q3	$907K	Sell	2,244 -255	-10%	-$103K	0.31%	63
2018 Q2	$902K	Buy	2,499 +166	+7%	+$59.9K	0.32%	62
2018 Q1	$750K	Buy	2,333 +605	+35%	+$194K	0.27%	67
2017 Q4	$634K	Buy	+1,728	New	+$634K	0.23%	71